CVS HEALTH CORP (CVS) Stock Earnings Estimates
NYSE:CVS • US1266501006
76.69 USD
-0.63 (-0.81%)
At close: Feb 20, 2026
76.8831 USD
+0.19 (+0.25%)
After Hours: 2/20/2026, 8:26:13 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 357.776B 10.95% | 372.809B 4.20% | 402.067B 7.85% | 409.954B 1.96% | 429.569B 4.78% | 452.878B 5.43% | 473.255B 4.50% | 497.816B 5.19% | 514.995B 3.45% | 547.437B 6.30% | 581.527B 6.23% | |
| EBITDA YoY % growth | N/A 0.50% | N/A -27.63% | N/A 14.51% | 17.909B 6.02% | 19.758B 10.32% | 21.966B 11.18% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 15.086B -7.39% | 10.038B -33.46% | 10.502B 4.62% | 15.48B 47.40% | 16.999B 9.81% | 19.087B 12.28% | 20.317B 6.44% | N/A | N/A | N/A | N/A | |
| Operating Margin | 4.22% | 2.69% | 2.61% | 3.78% | 3.96% | 4.21% | 4.29% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 8.74 0.46% | 5.42 -37.99% | 6.75 24.54% | 7.24 7.28% | 8.31 14.76% | 9.35 12.51% | 10.33 10.54% | 10.42 0.86% | 12.30 18.02% | 13.61 10.67% | 15.18 11.50% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.25 0.13% | 1.90 5.04% | 1.76 10.20% | 1.30 19.59% | 2.61 15.85% | 2.20 15.96% | 1.93 9.31% | 1.51 15.47% |
| Revenue Q2Q % growth | 96.117B 1.62% | 102.469B 3.59% | 106.413B 3.44% | 107.58B 1.79% | 104.572B 8.80% | 109.622B 6.98% | 114.024B 7.15% | 114.595B 6.52% |
| EBITDA Q2Q % growth | 5.163B 19.27% | 4.539B 16.71% | 4.415B 15.55% | 3.506B 12.08% | 5.991B 16.04% | 5.188B 14.30% | 4.507B 2.08% | 4.086B 16.54% |
| EBIT Q2Q % growth | 4.618B 36.87% | 4.017B 68.71% | 3.826B 51.95% | 2.886B 36.65% | 5.235B 13.36% | 4.579B 13.99% | 4.017B 4.99% | 3.276B 13.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 1.09 -8.40% | 1.00 | 0.09 | 8.80% |
| Q3 2025 Q2Q % growth | 1.60 46.79% | 1.38 | 0.22 | 15.69% |
| Q2 2025 Q2Q % growth | 1.81 -1.09% | 1.47 | 0.34 | 22.99% |
| Q1 2025 Q2Q % growth | 2.25 71.76% | 1.72 | 0.53 | 30.76% |
| Q4 2024 Q2Q % growth | 1.19 -43.87% | 0.94 | 0.25 | 27.26% |
| Q3 2024 Q2Q % growth | 1.09 -50.68% | 1.52 | -0.43 | -28.40% |
| Q2 2024 Q2Q % growth | 1.83 -17.19% | 1.75 | 0.08 | 4.69% |
| Q1 2024 Q2Q % growth | 1.31 -40.45% | 1.71 | -0.40 | -23.44% |
| Q4 2023 Q2Q % growth | 2.12 6.53% | 2.01 | 0.11 | 5.45% |
| Q3 2023 Q2Q % growth | 2.21 5.74% | 2.16 | 0.05 | 2.51% |
| Q2 2023 Q2Q % growth | 2.21 -7.92% | 2.13 | 0.08 | 3.81% |
| Q1 2023 Q2Q % growth | 2.20 -0.90% | 2.11 | 0.09 | 4.28% |
| Q4 2022 Q2Q % growth | 1.99 0.51% | 1.94 | 0.05 | 2.46% |
| Q3 2022 Q2Q % growth | 2.09 6.09% | 2.01 | 0.08 | 3.87% |
| Q2 2022 Q2Q % growth | 2.40 -0.83% | 2.20 | 0.20 | 9.31% |
| Q1 2022 Q2Q % growth | 2.22 8.82% | 2.18 | 0.04 | 2.05% |
| Q4 2021 Q2Q % growth | 1.98 52.31% | 1.95 | 0.03 | 1.58% |
| Q3 2021 Q2Q % growth | 1.97 18.67% | 1.80 | 0.17 | 9.72% |
| Q2 2021 Q2Q % growth | 2.42 -8.33% | 2.08 | 0.34 | 16.07% |
| Q1 2021 Q2Q % growth | 2.04 6.81% | 1.73 | 0.31 | 17.77% |
| Q4 2020 Q2Q % growth | 1.30 | 1.25 | 0.05 | 4.07% |
| Q3 2020 Q2Q % growth | 1.66 | 1.34 | 0.32 | 23.54% |
| Q2 2020 Q2Q % growth | 2.64 | 1.95 | 0.69 | 35.54% |
| Q1 2020 Q2Q % growth | 1.91 | 1.64 | 0.27 | 16.24% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 105.693B 8.17% | 104.629B | 1.064B | 1.02% |
| Q3 2025 Q2Q % growth | 102.871B 7.80% | 99.838B | 3.033B | 3.04% |
| Q2 2025 Q2Q % growth | 98.915B 8.42% | 95.444B | 3.471B | 3.64% |
| Q1 2025 Q2Q % growth | 94.588B 6.96% | 94.572B | 16M | 0.02% |
| Q4 2024 Q2Q % growth | 97.71B 4.15% | 98.16B | -450M | -0.46% |
| Q3 2024 Q2Q % growth | 95.428B 6.31% | 93.674B | 1.754B | 1.87% |
| Q2 2024 Q2Q % growth | 91.234B 2.60% | 92.411B | -1.177B | -1.27% |
| Q1 2024 Q2Q % growth | 88.437B 3.70% | 90.101B | -1.664B | -1.85% |
| Q4 2023 Q2Q % growth | 93.813B 11.89% | 91.309B | 2.504B | 2.74% |
| Q3 2023 Q2Q % growth | 89.764B 10.60% | 89.137B | 627M | 0.70% |
| Q2 2023 Q2Q % growth | 88.921B 10.27% | 87.398B | 1.523B | 1.74% |
| Q1 2023 Q2Q % growth | 85.278B 11.00% | 81.622B | 3.656B | 4.48% |
| Q4 2022 Q2Q % growth | 83.846B 9.45% | 76.971B | 6.875B | 8.93% |
| Q3 2022 Q2Q % growth | 81.159B 9.98% | 77.519B | 3.64B | 4.70% |
| Q2 2022 Q2Q % growth | 80.636B 11.04% | 77.133B | 3.503B | 4.54% |
| Q1 2022 Q2Q % growth | 76.826B 11.19% | 76.146B | 680M | 0.89% |
| Q4 2021 Q2Q % growth | 76.604B 10.14% | 76.428B | 176M | 0.23% |
| Q3 2021 Q2Q % growth | 73.794B 10.05% | 71.19B | 2.604B | 3.66% |
| Q2 2021 Q2Q % growth | 72.616B 11.13% | 71.002B | 1.614B | 2.27% |
| Q1 2021 Q2Q % growth | 69.097B 3.51% | 69.071B | 26M | 0.04% |
| Q4 2020 Q2Q % growth | 69.554B | 69.434B | 120M | 0.17% |
| Q3 2020 Q2Q % growth | 67.056B | 67.329B | -273M | -0.41% |
| Q2 2020 Q2Q % growth | 65.341B | 64.87B | 471M | 0.73% |
| Q1 2020 Q2Q % growth | 66.755B | 64.74B | 2.015B | 3.11% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.25% | 3.18% | 0.04% | 2.01% |
| Revenue | 0.04% | 1.09% | 0.01% | 0.52% |